World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
69
Citations
20242
World Ranking
2015
National Ranking
171

Kevin E. Brown publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kevin E. Brown sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 217 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Kevin E. Brown D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kevin E. Brown sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 69 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Kevin E. Brown is affiliated with Public Health England in the United Kingdom and has contributed extensively to research in the field of medicine, with a particular focus on infectious diseases. Their body of work includes over 300 publications, highlighting expertise in epidemiology, health, modeling and simulation, and neurology.

The scientist's research primarily centers on SARS-CoV-2 and COVID-19, encompassing clinical research studies and detection and testing methodologies. Their studies also address vaccine coverage and hesitancy, COVID-19 epidemiological research, long-term effects of COVID-19, and respiratory viral infections.

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Vaccine Coverage and Hesitancy
  • COVID-19 epidemiological studies
  • Long-Term Effects of COVID-19
  • Respiratory viral infections research

Frequent collaborators in their work include Mary Ramsay, Gayatri Amirthalingam, Shamez Ladhani, Annette Flanagin, and Tracy Frey. These partnerships are marked by multiple co-authored publications, reflecting ongoing research relationships.

Kevin E. Brown has published extensively in several reputable venues. Notable publication venues include:

  • JAMA Pediatrics
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Infection
  • SSRN Electronic Journal
  • Eurosurveillance

Significant papers authored include the following:

  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant, 2021, New England Journal of Medicine
  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study, 2021, BMJ
  • Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection, 2021, Nature Immunology
  • Effectiveness of COVID-19 vaccines against the B.1.617.2 variant, 2021, bioRxiv (Cold Spring Harbor Laboratory)
  • Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England, 2021, bioRxiv (Cold Spring Harbor Laboratory)

Their contributions primarily focus on the clinical effectiveness of vaccines during the COVID-19 pandemic and the immune response post-infection. This work provides data-driven insights into public health measures and vaccine impact.

Best Publications

  • Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

    Jamielopez L. Bernal;Nick Andrews;Charlotte Gower;Eileen Gallagher

  • Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

    James Lopez Bernal;James Lopez Bernal;James Lopez Bernal;Nicholas Andrews;Nicholas Andrews;Charlotte Gower;Chris Robertson

  • Erythrocyte P antigen: cellular receptor for B19 parvovirus

    Kevin E. Brown;Stacie M. Anderson;Neal S. Young

  • Human Parvovirus B19

    Erik D. Heegaard;Kevin E. Brown

  • Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity

    Nikola Kaludov;Kevin E. Brown;Robert W. Walters;Joseph Zabner

  • Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer.

    Robert W. Walters;Su Min P. Yi;Shaf Keshavjee;Kevin E. Brown

  • Resistance to Parvovirus B19 Infection Due to Lack of Virus Receptor (Erythrocyte P Antigen)

    Kevin E. Brown;Jonathan R. Hibbs;Giorgio Gallinella;Stacie M. Anderson

  • Hepatitis-Associated Aplastic Anemia

    K E Brown;J Tisdale;A J Barrett;C E Dunbar

  • Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.

    Jianmin Zuo;Alexander C Dowell;Hayden Pearce;Kriti Verma

  • Effectiveness of COVID-19 vaccines against the B.1.617.2 variant

    Jamie Lopez Bernal;Jamie Lopez Bernal;Jamie Lopez Bernal;Nick Andrews;Nick Andrews;Charlotte Gower;Eileen Gallagher

  • Nucleotide Sequencing and Generation of an Infectious Clone of Adeno-Associated Virus 3

    Shin-Ichi Muramatsu;Hiroaki Mizukami;Neal S. Young;Kevin E. Brown

  • Review of the effect of measles vaccination on the epidemiology of SSPE

    H Campbell;N Andrews;K E Brown;E Miller

  • Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England

    Jamie Lopez Bernal;Jamie Lopez Bernal;Jamie Lopez Bernal;Nick Andrews;Nick Andrews;Charlotte Gower;Julia Stowe

  • Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.

    Jaroslaw P. Maciejewski;Dean Follmann;Ryotaro Nakamura;Yogen Saunthararajah

  • Congenital anaemia after transplacental B19 parvovirus infection

    K.E Brown;S.W Green;J Antunez de Mayolo;N.S Young

  • Identification and characterization of a second novel human erythrovirus variant, A6.

    Quang Tri Nguyen;Susan Wong;Erik D. Heegaard;Kevin E. Brown

  • Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors

    Atsushi Handa;Shin-ichi Muramatsu;Jianming Qiu;Hiroaki Mizukami

  • Adeno-associated virus 2 co-receptors?

    Jianming Qiu;Hiro Mizukami;Kevin E. Brown

  • Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor

    Sirika Pillay;Wei Zou;Fang Cheng;Andreas S. Puschnik

  • ADENO-ASSOCIATED VIRUS TYPE 2 BINDS TO A 150-KILODALTON CELL MEMBRANE GLYCOPROTEIN

    Hiroaki Mizukami;Neal S. Young;Kevin E. Brown

  • Rabaptin-5 is a novel fusion partner to platelet-derived growth factor β receptor in chronic myelomonocytic leukemia

    Magnus K. Magnusson;Kristin E. Meade;Kevin E. Brown;Diane C. Arthur

Frequent Co-Authors

Shamez N. Ladhani
Shamez N. Ladhani UK Health Security Agency
Mary Ramsay
Mary Ramsay UK Health Security Agency
Gayatri Amirthalingam
Gayatri Amirthalingam Public Health England
Neal S. Young
Neal S. Young National Institutes of Health
Nick Andrews
Nick Andrews Salk Institute for Biological Studies
Maria Zambon
Maria Zambon Public Health England
Joanna Ellis
Joanna Ellis Public Health England
Paul Moss
Paul Moss University of Birmingham
Mick N. Mulders
Mick N. Mulders World Health Organization
Richard M. Myers
Richard M. Myers HudsonAlpha Institute for Biotechnology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors not only to laboratory and research roles but also to allied health careers. One emerging pathway is through medical coding and health information management, fields that intersect closely with biological sciences. Aspiring professionals can explore certification opportunities, such as becoming a certified professional coder (cpc), which equips individuals with expertise in medical billing and coding—key skills in healthcare administration.

For those interested in broader management roles within healthcare data, pursuing a health information management degree is vital. Understanding the health information management salary entry-level expectations can guide recent graduates in choosing the right career trajectory.

Fortunately, there are flexible educational options available, including the best online health information management degree cahiim accredited programs, which combine convenience with industry-recognized standards. For those seeking quicker certifications, exploring fast online medical billing and coding certification programs can be an effective way to enter the workforce rapidly while gaining essential healthcare knowledge.

Best Scientists Citing Kevin E. Brown

Trending Scientists

Recently Published Articles